top of page
Menu
Close
Home
Science
Pipeline
Team
Newsroom
Careers
Contact
Home
Science
Pipeline
Team
Newsroom
Careers
Contact
Onchilles Pharma
contact us
Contact us
First name
Last name
Email
*
Message
*
Submit
Onchilles Pharma
pioneering the use of the ELANE pathway to create the next-generation of pan-cancer therapeutics
Location
9880 Campus Point Drive, Suite 420 San Diego, California 92121
Subscribe To Our Newsletter
Keep up to date with all the latest news from Onchilles Pharma
First name
Last name
Email
*
Yes, subscribe me to your newsletter.
Submit
latest news
Keep up to date with all the latest news from Onchilles Pharma
Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway
First-in-class therapeutic, N17350, demonstrates potent and selective tumor killing in chemotherapy-naïve and chemotherapy-treated ovarian cancer patient-derived models
Press Release
Apr 25
3 min read
Onchilles Pharma to Present New Preclinical Data for N17350 at AACR 2025
March 25, 2025 N17350 is a next-generation cytotoxic agent designed to selectively kill cancer cells independent of anatomical locations,...
Press Release
Mar 25
2 min read
Home
Science
Pipeline
Team
Newsroom
bottom of page
